Tradestie Institutional Equity Comparison Engine

ACB vs IONX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACB Overall Edge

ACB Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aurora Cannabis Inc. Common Shares (ACB) driven by superior Valuation, Growth & Margin, Momentum & Technical while IONX counters with relative strength in Options & Structure. Fundamentally, ACB trades at 109.9x Forward P/E with -13.8% operating margin (-8.8% YoY revenue) versus IONX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACB sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against IONX sits in UNCLASSIFIED (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACB
ACB 109.9x vs IONX N/M Fwd P/E
Growth & Margin Winner ACB
Op Margin -13.8% vs N/A ยท YoY -8.8% vs N/A
Momentum & Technical Winner ACB
1Y +5.0% vs -84.5% ยท 52W Pos 54% vs 0%
Options & Structure Winner IONX
CONSOLIDATION (6th %ile IV) vs UNCLASSIFIED (4th %ile IV)
ACB NASDAQ
Aurora Cannabis Inc. Common Shares
Medicinal Chemicals & Botanical Products
$4.61
-6.68% 1D
Market Cap $324.8M
1M Return +15.54%
1Y Return +5.01%
Forward P/E 109.9x
Unified AI Score
40.1 / 100 SELL
Tech 15.0 Fund 40.0 Flow 61.0 Mom 50.0
IONX NASDAQ
Defiance Daily Target 2X Long IONQ ETF
Institutional Equity
$8.27
-16.55% 1D
Market Cap N/A
1M Return -36.82%
1Y Return -84.51%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 45.0 Fund 51.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACB +5.01% IONX -84.51% Spread: +89.52 pp (ACB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACB TTM Op. Margin: -13.8% IONX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACB vs IONX. Trailing 12-month operating profitability (ACB -13.8% vs IONX N/A) and valuation multiples (ACB 109.9x vs IONX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACB (9) vs IONX (1)
Institutional Metric ACB IONX Criterion Row Winner
Market Capitalization Scale $324.8M N/A Larger Scale ACB
Trailing P/E Ratio Valuation 109.9x N/M Lower Multiple ACB
Forward P/E Ratio Valuation 109.9x N/M Lower Multiple ACB
Revenue Growth (YoY) Growth -8.8% N/A Higher Growth ACB
Operating Margin (TTM) Profitability -13.8% N/A Higher Margin ACB
Net Profit Margin Profitability -38.2% N/A Higher Margin ACB
Return on Equity (ROE) Capital Efficiency -9.4% N/A Higher ROE ACB
52-Week Range Position Momentum 54% ($3โ€“$6) 0% ($8โ€“$108) Stronger Trend ACB
Beta / 30D Volatility Risk Regime 1.07ฮฒ ยท 87% Vol 6.79ฮฒ ยท 232% Vol Lower Realized Risk ACB
Unified Institutional Score Composite Signal 40.1 / 100 (SELL) 48.8 / 100 (HOLD) Higher Composite IONX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACB vs IONX Buy Guide
ACB CONSOLIDATION
29d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IONX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live IONX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACB nor IONX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.